Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Open Access
- 1 May 2004
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 5 (5), 455-463
- https://doi.org/10.1016/s1535-6108(04)00114-x
Abstract
Inappropriate transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development of leukemia. We now identify faulty expression of a specific mediator of transcriptional repression in a solid tumor. Loss of the adenomatosis polyposis coli (APC) tumor suppressor induces HDAC2 expression depending on the Wnt pathway and c-Myc. Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice. HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colonic cancer cells. Interference with HDAC2 by valproic acid largely diminishes adenoma formation in APCmin mice. These findings point toward HDAC2 as a particularly relevant potential target in cancer therapy.Keywords
This publication has 45 references indexed in Scilit:
- The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer CellsCell, 2002
- Anti‐tumor mechanisms of valproate: A novel role for an old drugMedicinal Research Reviews, 2002
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Translating the Histone CodeScience, 2001
- Interactions between BRCA Proteins and DNA StructureExperimental Cell Research, 2001
- The language of covalent histone modificationsNature, 2000
- The Hallmarks of CancerCell, 2000
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992